Illustration of a clinic building (not a photo of Retinovitreous Associates Ltd)
Illustration

Michael A. Klufas, MD

Ophthalmology in Plymouth Meeting, PA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • 16 years since graduation
  • Public record — not managed by the clinician

About Dr. Michael Klufas

Dr. Michael Klufas is a physician specializing in ophthalmology practicing in Plymouth Meeting, PA, a graduate of Js Weill Medical College, Cornell University (2010). Records list 4 practice addresses. Affiliated with Wills Eye Hospital. Treated 1,996 Medicare patients in 2024.

Provider details

SpecialtyOphthalmologyOther ophthalmology doctors in Plymouth Meeting
CredentialsMD
EducationJs Weill Medical College, Cornell University, 2010CMS Doctors and Clinicians
GenderMale
NPI number1346558392National Provider Identifier (CMS NPPES), issued September 2010
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Dr. Michael Klufas' specialties and state licenses

  • Ophthalmology Primary
    License: NJ 25MA09823500
  • Ophthalmology
    License: DE C1-0011621
  • Ophthalmology
    License: PA MD456843
  • Retina Specialist
    License: DE C1-0011621
  • Retina Specialist
    License: PA MD456843
  • Retina Specialist
    License: NJ 25MA09823500

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Michael Klufas practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Michael Klufas

  • Wills Eye HospitalHospital · Philadelphia, PA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Michael Klufas' Medicare quality score (MIPS 2024)

98.8/100final MIPS score
97.9quality
100promoting interoperability
40improvement activities

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Michael Klufas' Medicare patients and services (2024)

1,996Medicare patients
85,494services billed
77average patient age
60%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Imaging of retina5,618$44.43
Injection of drug into eye3,947$143.28
Established patient problem focused exam of visual system2,961$97.48
Extended exam of the back part of the eye with retinal drawing1,449$26.93
Established patient complete exam of visual system1,125$137.54
Unclassified biologics335$1,970.52
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more267$182.91
2d ultrasound scan of eye tissue and structures101$52.87

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis45%
  • Diabetes37%
  • Ischemic heart disease33%
  • Chronic kidney disease28%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Michael Klufas (2025)

$77,890.54 in 76 general payments reported in 2025, plus $2,977.19 in research payments.

TypePaymentsAmount
Compensation for services other than consulting12$57,380.19
Consulting fees4$12,184
Travel and lodging41$7,255.67
Food and beverage19$1,070.68

Paying companies: Regeneron Healthcare Solutions, Inc. ($41,217.07), Genentech USA, Inc. ($28,056.93), Genentech, Inc. ($5,400), Apellis Pharmaceuticals, Inc. ($3,024), Dutch Ophthalmic, USA ($165.52), Bausch & Lomb Americas Inc. ($27.02).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Retinovitreous Associates Ltd

Questions about Dr. Michael Klufas

What kind of clinician is Dr. Michael Klufas?

Dr. Michael Klufas is listed as a physician specializing in ophthalmology.

Where does Dr. Michael Klufas practice?

Retinovitreous Associates Ltd at 4060 Butler Pike, Suite 200, Plymouth Meeting, PA 19462, and 3 other addresses in the records.

What is the office phone number for Dr. Michael Klufas?

The listed office number is (800) 331-6634. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Michael Klufas?

The National Provider Identifier is 1346558392.

Does Dr. Michael Klufas accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Michael Klufas affiliated with?

Wills Eye Hospital.

Where did Dr. Michael Klufas go to medical school?

Js Weill Medical College, Cornell University, graduating in 2010.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2026-09-30
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call Retinovitreous Associates Ltd at (800) 331-6634 or visit the clinic page to check availability.

Call now
0 clinics selected Compare